Teladoc Health Target of Unusually Large Options Trading (NYSE:TDOC)

Key Points

• Teladoc Health (NYSE:TDOC) experienced a significant increase in options trading, with 52,865 call options purchased, marking a 172% rise compared to average volumes.
• Analysts have mixed views on Teladoc, with an average price target of $9.80, while ratings include six Buy recommendations and eleven Hold ratings.
• The company reported a Q2 loss of ($0.19) per share, surpassing estimates, and year-over-year revenue declined by 1.6%, highlighting ongoing financial challenges.

Teladoc Health, Inc. (NYSE:TDOC - Get Free Report) saw unusually large options trading on Tuesday. Stock investors bought 52,865 call options on the company. This represents an increase of approximately 172% compared to the average volume of 19,422 call options.

Wall Street Analysts Forecast Growth

Several equities analysts have issued reports on the company. Evercore ISI boosted their price target on Teladoc Health from $7.00 to $8.00 and gave the company an "in-line" rating in a research note on Wednesday, July 9th. Truist Financial dropped their price target on Teladoc Health from $10.00 to $9.00 and set a "hold" rating on the stock in a research report on Tuesday, May 27th. Mizuho started coverage on Teladoc Health in a report on Friday, July 25th. They issued a "neutral" rating and a $10.00 price target on the stock. Finally, Bank of America decreased their price objective on Teladoc Health from $8.00 to $7.00 and set a "neutral" rating on the stock in a report on Wednesday, May 28th. Six research analysts have rated the stock with a Buy rating and eleven have assigned a Hold rating to the stock. According to data from MarketBeat, Teladoc Health has an average rating of "Hold" and an average price target of $9.80.

Hedge Funds Weigh In On Teladoc Health

A number of institutional investors and hedge funds have recently added to or reduced their stakes in TDOC. ProShare Advisors LLC raised its holdings in shares of Teladoc Health by 50.7% in the 4th quarter. ProShare Advisors LLC now owns 48,480 shares of the health services provider's stock valued at $441,000 after buying an additional 16,312 shares during the period. Vise Technologies Inc. increased its position in Teladoc Health by 4.9% during the fourth quarter. Vise Technologies Inc. now owns 30,179 shares of the health services provider's stock worth $274,000 after buying an additional 1,405 shares in the last quarter. Brucke Financial Inc. acquired a new stake in shares of Teladoc Health during the fourth quarter worth $92,000. PKO Investment Management Joint Stock Co acquired a new position in Teladoc Health in the fourth quarter valued at $227,000. Finally, Wealth Enhancement Advisory Services LLC lifted its stake in shares of Teladoc Health by 22.1% during the fourth quarter. Wealth Enhancement Advisory Services LLC now owns 14,725 shares of the health services provider's stock worth $134,000 after purchasing an additional 2,662 shares in the last quarter. Institutional investors and hedge funds own 76.82% of the company's stock.

Teladoc Health Price Performance

Shares of Teladoc Health stock traded up $0.62 during trading hours on Tuesday, hitting $8.81. The company's stock had a trading volume of 4,586,233 shares, compared to its average volume of 6,662,848. The company has a debt-to-equity ratio of 0.70, a quick ratio of 2.58 and a current ratio of 2.67. The company has a market cap of $1.56 billion, a PE ratio of -7.36 and a beta of 1.84. Teladoc Health has a 12-month low of $6.35 and a 12-month high of $15.21. The business has a 50 day moving average price of $7.65 and a two-hundred day moving average price of $7.62.

Teladoc Health (NYSE:TDOC - Get Free Report) last posted its earnings results on Tuesday, July 29th. The health services provider reported ($0.19) EPS for the quarter, topping analysts' consensus estimates of ($0.27) by $0.08. The company had revenue of $631.90 million for the quarter, compared to the consensus estimate of $621.91 million. Teladoc Health had a negative return on equity of 10.13% and a negative net margin of 8.16%.The firm's revenue for the quarter was down 1.6% on a year-over-year basis. During the same period in the previous year, the business earned ($0.38) earnings per share. Teladoc Health has set its Q3 2025 guidance at -0.350--0.200 EPS. FY 2025 guidance at -1.350--1.000 EPS. Analysts expect that Teladoc Health will post -1.16 earnings per share for the current fiscal year.

Teladoc Health Company Profile

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.